A detailed history of Signal Point Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Signal Point Asset Management, LLC holds 5,987 shares of ABT stock, worth $672,938. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,987
Previous 5,952 0.59%
Holding current value
$672,938
Previous $676,000 7.99%
% of portfolio
0.18%
Previous 0.21%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$100.73 - $112.44 $3,525 - $3,935
35 Added 0.59%
5,987 $622,000
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $14,610 - $16,916
151 Added 2.6%
5,952 $575,000
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $8,568 - $10,086
81 Added 1.42%
5,801 $673,000
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $8,054 - $9,489
-74 Reduced 1.28%
5,720 $685,000
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $63,000 - $68,652
-600 Reduced 9.38%
5,794 $635,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $32,074 - $38,951
350 Added 5.79%
6,394 $696,000
Q2 2020

Jul 28, 2020

BUY
$76.57 - $98.0 $21,056 - $26,950
275 Added 4.77%
6,044 $551,000
Q1 2020

Apr 23, 2020

BUY
$62.82 - $91.86 $10,993 - $16,075
175 Added 3.13%
5,769 $455,000
Q4 2019

Jan 30, 2020

SELL
$78.51 - $87.4 $1,413 - $1,573
-18 Reduced 0.32%
5,594 $486,000
Q3 2019

Oct 18, 2019

BUY
$81.84 - $88.74 $1,473 - $1,597
18 Added 0.32%
5,612 $470,000
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $14,576 - $17,000
-200 Reduced 3.45%
5,594 $470,000
Q4 2018

Jan 22, 2019

SELL
$65.56 - $74.27 $17,438 - $19,755
-266 Reduced 4.39%
5,794 $419,000
Q4 2017

Jan 31, 2018

BUY
$53.68 - $57.47 $325,300 - $348,268
6,060 New
6,060 $346,000
Q4 2017

Jan 31, 2018

SELL
$53.68 - $57.47 $325,300 - $348,268
-6,060 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $291,243 - $325,058
6,060
6,060 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Signal Point Asset Management, LLC Portfolio

Follow Signal Point Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Point Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Point Asset Management, LLC with notifications on news.